| Product Information |
|
| Registration Number |
BRP-130
|
| Generic Name |
Trastuzumab
|
| Brand Name |
Herticad
|
| Dosage Strength |
440 mg
|
| Dosage Form |
Powder for Concentrate for Solution for Infusion.
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Each box contains: Type I borosilicate glass vial with grey bromobutyl rubber stopper and aluminum seal with polypropylene flip-off cap (as Trastuzumab) + Type I borosilicate glass vial with grey bromobutyl rubber stopper and aluminum seal with polypropylene flip-off cap (as Bacteriostatic Water for Injection) x 20 mL.
|
| Pharmacologic Category |
Monoclonal Antibodies
|
| Manufacturer |
Joint Stock Company Biocad
|
| Country of Origin |
Russia
|
| Trader |
N/A
|
| Importer |
Ambitech Biopharmaceuticals Inc.
|
| Distributor |
Ambitech Biopharmaceuticals Inc.
|
| Application Type |
Initial (Reapplication)
|
| Issuance Date |
09 November 2023
|
| Expiry Date |
09 November 2028
|